Tag: United States Patent and Trademark Office

December 5, 2019

Dixie Brands Obtains Patent for Cannabinoid Delivery Method

Dixie Brands' subsidiary has received approval for a patent covering the development of unique cannabinoid delivery methods.
January 23, 2019

Aurora Spine Announces New Patent for Its Minimally Invasive Spinal Implants Allowed by the United States Patent Office

Aurora Spine Corporation (TSXV:ASG) announced today the issuance by the United States Patent and Trademark Office (USPTO) of United States...
December 20, 2018

Glance Technologies Files Provisional Patent with USPTO

Glance Technologies (CSE:GET) announced that it has filed a provisional patent application with the United States Patent and Trademark Office....
December 19, 2018

Adamas Announces Issuance of New U.S. Patent Covering GOCOVRI

Adamas Pharmaceuticals (Nasdaq:ADMS), a fully-integrated pharmaceutical company pioneering time-dependent medicines for central nervous system (CNS) disorders, today announced that a new...
December 13, 2018

Corcept Therapeutics Announces Allowance of Additional Patent Covering the Use of Korlym to Treat Patients With Cushing’s Syndrome

Corcept Therapeutics (NASDAQ:CORT) announced today that the United States Patent and Trademark Office has given notice that it will allow...
December 4, 2018

Translate Bio Expands Patent Portfolio with Newly Issued U.S. Patent Relating to Its Messenger RNA Therapeutics Platform

Translate Bio (Nasdaq:TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat...
November 20, 2018

New U.S. patent related to Oasmia Pharmaceutical’s nanotechnology platform XR17

Oasmia Pharmaceutical (Nasdaq:OASM) announces that the United States Patent and Trademark Office (USPTO) has issued a notification of allowance of...